Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2019
Price : $35 *
At a glance
- Drugs Calfactant (Primary)
- Indications Respiratory distress syndrome
- Focus Therapeutic Use
- Sponsors Ony
- 11 Mar 2019 Status changed from active, no longer recruiting to completed.
- 27 Jun 2018 Planned End Date changed from 31 Dec 2018 to 31 Jul 2018.
- 27 Jun 2018 Status changed from recruiting to active, no longer recruiting.